![]() | |
Identifiers | |
---|---|
| |
PubChem CID | |
ChemSpider | |
Chemical and physical data | |
Formula | C18H25BrN4O2 |
Molar mass | 409.328 g·mol−1 |
3D model (JSmol) | |
| |
|
ADB-5'Br-BUTINACA (ADB-B-5Br-INACA) is an indazole-3-carboxamide based synthetic cannabinoid receptor agonist which has been sold as a designer drug, [1] first detected in Philadelphia in the US in May 2022, [2] and subsequently found in South Korea, [3] Portugal and Sweden. [4] It is specifically listed as an illegal drug in Italy, [5] South Korea [6] and several states in the US, [7] [8] and controlled under analogue legislation in various other jurisdictions.